Fujun Lin

640 total citations
22 papers, 460 citations indexed

About

Fujun Lin is a scholar working on Nephrology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Fujun Lin has authored 22 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Nephrology, 9 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Fujun Lin's work include Renal Diseases and Glomerulopathies (6 papers), Renal and related cancers (5 papers) and T-cell and B-cell Immunology (3 papers). Fujun Lin is often cited by papers focused on Renal Diseases and Glomerulopathies (6 papers), Renal and related cancers (5 papers) and T-cell and B-cell Immunology (3 papers). Fujun Lin collaborates with scholars based in China, United Kingdom and Cyprus. Fujun Lin's co-authors include Gengru Jiang, Xiangru Wu, Gengru Jiang, Jun Zou, Ping Wu, Jun Zou, Wei Niu, Shuang Liu, Fan Bian and Daniel P. Gale and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of the American Society of Nephrology.

In The Last Decade

Fujun Lin

21 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fujun Lin China 12 190 160 126 63 61 22 460
Gengru Jiang China 14 180 0.9× 168 1.1× 182 1.4× 130 2.1× 16 0.3× 34 530
Tzu-Ting Hsu Australia 4 139 0.7× 182 1.1× 68 0.5× 42 0.7× 75 1.2× 4 468
Hikaru Koide Japan 13 251 1.3× 115 0.7× 62 0.5× 63 1.0× 38 0.6× 18 525
Natalia Duque Spain 6 180 0.9× 132 0.8× 144 1.1× 33 0.5× 32 0.5× 12 382
Osamu Asai Japan 10 276 1.5× 137 0.9× 189 1.5× 103 1.6× 21 0.3× 33 694
Djillali Sahali France 7 209 1.1× 159 1.0× 85 0.7× 59 0.9× 12 0.2× 13 423
S. P. Makker United States 13 188 1.0× 96 0.6× 118 0.9× 27 0.4× 55 0.9× 26 404
Giuseppina Cerullo Italy 11 306 1.6× 130 0.8× 94 0.7× 47 0.7× 21 0.3× 14 528
William G. Couser United States 8 372 2.0× 295 1.8× 91 0.7× 60 1.0× 38 0.6× 8 651
Zeng Caihong China 9 228 1.2× 176 1.1× 67 0.5× 24 0.4× 113 1.9× 14 389

Countries citing papers authored by Fujun Lin

Since Specialization
Citations

This map shows the geographic impact of Fujun Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fujun Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fujun Lin more than expected).

Fields of papers citing papers by Fujun Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fujun Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fujun Lin. The network helps show where Fujun Lin may publish in the future.

Co-authorship network of co-authors of Fujun Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Fujun Lin. A scholar is included among the top collaborators of Fujun Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fujun Lin. Fujun Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Fujun, et al.. (2023). ASH2L Controls Ureteric Bud Morphogenesis through the Regulation of RET/GFRA1 Signaling Activity in a Mouse Model. Journal of the American Society of Nephrology. 34(6). 988–1002. 5 indexed citations
2.
Zong, Xue, et al.. (2022). Identification and functional characterization of the first deep intronic GLA mutation (IVS4+1326C>T) causing renal variant of Fabry disease. Orphanet Journal of Rare Diseases. 17(1). 237–237. 5 indexed citations
3.
Lin, Fujun, Heena V. Lad, Francesca Mazzacuva, et al.. (2022). Tissue Proteome of 2-Hydroxyacyl-CoA Lyase Deficient Mice Reveals Peroxisome Proliferation and Activation of ω-Oxidation. International Journal of Molecular Sciences. 23(2). 987–987. 7 indexed citations
4.
Fan, Yanjie, Lili Wang, Yu Sun, et al.. (2020). Diagnostic yield of additional exome sequencing after the detection of long continuous stretches of homozygosity (LCSH) in SNP arrays. Journal of Human Genetics. 66(4). 409–417. 2 indexed citations
5.
Lin, Fujun, Xi Zhang, Lusheng Huang, et al.. (2019). De novo Cardiac Valve Calcification after Hemodialysis in End-Stage Renal Disease Patients Predicts Future Cardiovascular Events: A Longitudinal Cohort Study. Cardiorenal Medicine. 9(4). 229–239. 8 indexed citations
6.
Tan, Peng, Yichao Du, Bing Guo, et al.. (2019). SPOP suppresses pancreatic cancer progression by promoting the degradation of NANOG. Cell Death and Disease. 10(11). 794–794. 27 indexed citations
7.
Qian, Xiaoqian, et al.. (2019). Survival Motor Neuron (SMN) Protein Insufficiency Exacerbates Renal Ischemia/Reperfusion Injury. Frontiers in Physiology. 10. 559–559. 7 indexed citations
8.
Niu, Wei, Fujun Lin, Shuang Liu, et al.. (2018). Micro RNA-155 inhibitor as a potential therapeutic strategy for the treatment of acute kidney injury (AKI): a nanomedicine perspective. RSC Advances. 8(29). 15890–15896. 16 indexed citations
9.
Lin, Fujun, Xi Zhang, Lusheng Huang, et al.. (2018). Impact of hemoglobin variability on cardiovascular mortality in maintenance hemodialysis patients. International Urology and Nephrology. 50(9). 1703–1712. 11 indexed citations
11.
Lin, Fujun, Lei Yao, Xueqing Hu, et al.. (2018). First identification of PODXL nonsense mutations in autosomal dominant focal segmental glomerulosclerosis. Clinical Science. 133(1). 9–21. 8 indexed citations
12.
Lin, Fujun, Dan Zhang, Juan Chang, et al.. (2017). THSD7A-associated membranous nephropathy in a patient with neurofibromatosis type 1. European Journal of Medical Genetics. 61(2). 84–88. 18 indexed citations
13.
Fan, Ying, Wenzhen Xiao, Kyung Lee, et al.. (2017). Inhibition of Reticulon-1A–Mediated Endoplasmic Reticulum Stress in Early AKI Attenuates Renal Fibrosis Development. Journal of the American Society of Nephrology. 28(7). 2007–2021. 60 indexed citations
14.
Lin, Fujun, Wei Lu, Daniel P. Gale, et al.. (2016). Delayed diagnosis of Townes-Brocks syndrome with multicystic kidneys and renal failure caused by a novel SALL1 nonsense mutation: A case report. Experimental and Therapeutic Medicine. 11(4). 1249–1252. 5 indexed citations
15.
Gale, Daniel P., Fujun Lin, Nadia Khan, et al.. (2016). A novel COL4A1 frameshift mutation in familial kidney disease: the importance of the C-terminal NC1 domain of type IV collagen. Nephrology Dialysis Transplantation. 31(11). 1908–1914. 19 indexed citations
16.
Zou, Jun, Yi Yu, Ping Wu, et al.. (2016). Serum phosphorus is related to left ventricular remodeling independent of renal function in hospitalized patients with chronic kidney disease. International Journal of Cardiology. 221. 134–140. 21 indexed citations
17.
Wu, Ping, Lijing Sun, Bo Zhou, et al.. (2016). miR-204 regulates epithelial-mesenchymal transition by targeting SP1 in the tubular epithelial cells after acute kidney injury induced by ischemia-reperfusion. Oncology Reports. 37(2). 1148–1158. 55 indexed citations
18.
Lin, Fujun, Fan Bian, Jun Zou, et al.. (2014). Whole exome sequencing reveals novel COL4A3 and COL4A4mutations and resolves diagnosis in Chinese families with kidney disease. BMC Nephrology. 15(1). 175–175. 21 indexed citations
19.
Yuan, Xiangliang, Yingxia Zheng, W Wang, et al.. (2012). Increased CD45RA+FoxP3low Regulatory T Cells with Impaired Suppressive Function in Patients with Systemic Lupus Erythematosus. PLoS ONE. 7(4). e34662–e34662. 65 indexed citations
20.
Lin, Fujun, et al.. (2012). Imbalance of regulatory T cells to Th17 cells in IgA nephropathy. Scandinavian Journal of Clinical and Laboratory Investigation. 72(3). 221–229. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026